Heron Therapeutics, Inc.
HRTX· Nasdaq
HRTXHeron Therapeutics, Inc.
Filed Mar 7, 2014 · 10-K · 66 days after period end · 0001193125-14-087658
| Metric | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$14.04M | -$7.74M | -$4.26M | — |
| EPS Diluted | -$0.75 | -$0.51 | -$0.02 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Heron Therapeutics, Inc. · CIK 818033 · Engraved from SEC EDGAR
ended Dec 31, 2013 · filed Mar 7, 2014 · 66 d after period end
